Cancer Genetics and Epigenetics 2019, Vol.7, No.1, 1-10
9
Matakidou A., Eisen T., and Houlston R.S., 2003, TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis, Mutagenesis, 18(4):
377-385
PMid:12840112
Moher D., Liberati A., Tetzlaff J., and Altman D.G., 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ,
339: b2535
PMid:19622551 PMCid:PMC2714657
Nan H., Qureshi A.A., Hunter D.J., and Han J., 2008, Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response
and cutaneous melanoma risk, Br J Dermatol, 159: 314-321
PMid:18510673 PMCid:PMC2753198
Parkin D.M., Bray F., Ferlay J., and Jemal A., 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55: 74-108
PMid:15761078
Pietsch E.C., Humbey O., and Murphy M.E., 2006, Polymorphisms in the p53 pathway, Oncogene, 25: 1602-1611
PMid:16550160
Salanti G., Amountza G., Ntzani E.E., an
2005, Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting,
deviations, and power, Eur J Hum Genet, 13(7): 840-848
PMid:15827565
Sousa H., Santos A.M., Catarino R., Pinto D., Vasconcelos A., Lopes C., Breda E., and Medeiros R., 2006, Linkage of TP53 codon 72 pro/pro genotype as
predictive factor for nasopharyngeal carcinoma development, Eur J Cancer Prev, 15: 362-366
PMid:16835507
Sousa H., Santos A.M., Pinto D., and Medeiros R., 2007, Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis
review within European populations, Int J Mol Med, 20(5): 731-741
PMid:17912468
Tiwawech D., Srivatanakul P., Karaluk A., and Ishida T., 2003, The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma, Cancer Lett, 198: 69-75
Tsai M.H., Lin C.D., Hsieh Y.Y.,
, and Tsai C.H., 2002, Prognostic significance of the proline form of p53 codon 72
polymorphism in nasopharyngeal carcinoma, Laryngoscope, 112: 116-119
PMid:11802048
Tsui I.F., Poh C.F., Garnis C., Rosin M.P., Zhang L., and Lam W.L., 2009, Multiple pathways in the FGF signaling network are frequently deregulated by gene
amplification in oral dysplasias, Int J Cancer, 125(9): 2219-2228
PMid:19623652 PMCid:PMC2761835
Xiao M., Zhang L., Zhu X., Huang J., Jiang H., Hu S., and Liu Y., 2010, Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of
nasopharyngeal carcinoma in a Chinese population, BMC Cancer, 10: 147-154
PMid:20398418 PMCid:PMC2861659
Xie X.X., Wang H., Jin H.K., et al., 2013, Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in
nasopharyngeal carcinoma, Radiation Oncology, 8: 117-127
PMid:23663243 PMCid:PMC3720183
Xu T., Xu Z.C., Zou Q.
, an
2012, P53 Arg72Pro polymorphism and bladder cancer risk-meta-analysis evidence for a link in Asians but not
Caucasians, Asian Pac J Cancer Prev, 13(5): 2349-2354
PMid:22901221
Yung W.C., Ng M.H., Sham J.S., and Choy D.T., 1997, p53 codon 72 polymorphism in nasopharyngeal carcinoma, Cancer Genet Cytogenet, 93: 181-182
Zhang X.A., Chen X., Zhai Y., et al., 2014, Combined effects of genetic variants of the PTEN, AKT1, MDM2 and p53 genes on the risk of nasopharyngeal
carcinoma, PLoS ONE, 9(3): e92135
PMid:24632578 PMCid:PMC3954877
